Antibody News

Antibody News - Updated Daily

XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical ... - Market...
XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical ...
MarketWatch - 10 hours ago
The Company's expanding pipeline includes XOMA 052, an anti-IL-1 beta antibody, and XOMA 629, a synthetic antimicrobial peptide compound derived from ...
Bio-Rad Describes Methods for Protein A Antibody Purification - PharmaLive.co...
Bio-Rad Describes Methods for Protein A Antibody Purification
PharmaLive.com (press release), PA - 13 hours ago
The technical note provides results that demonstrate how the Profinia protein purification system is ideal for the efficient purification of antibodies ...
Using Tobacco to Fight Cancer - HealthNews
HealthNews
Using Tobacco to Fight Cancer
HealthNews, CA - 11 hours ago
The vaccine is developed by isolating the antibody gene from the patient's own tumor, then infecting the tobacco plant with the gene-carrying virus by ...
Plants Make Vaccine for Treating Type of Cancer in Stanford Study MarketWatch
Tobacco - cancers cause or cure? In-PharmaTechnologist.com
Tobacco 'could help treat cancer' BBC News
Medical News Today - Therapeutics Daily (subscription) (press release)
all 173 news articles
Immunocellular Therapeutics signs agreement with Antitope - Cambridge Network
Immunocellular Therapeutics signs agreement with Antitope
Cambridge Network, UK - 16 hours ago
?We have made solid progress in our antibody therapy program including signing research agreements with Antitope and George Mason University and presenting ...
Thermo buys Affinity BioReagents - LabTechnologist.com
Thermo buys Affinity BioReagents
LabTechnologist.com, UK - 9 hours ago
By Dr Matt Wilkinson 24-Jul-2008 - Thermo Fisher Scientific has followed up its acquisition of Open Biosystems with the purchase of antibody experts ...
Lab suppliers post solid Q2 growth despite the credit crisis LabTechnologist.com
all 2 news articles
Roche starts acquisition process of ARIUS to gain access to new ... - FOXBusi...
Roche starts acquisition process of ARIUS to gain access to new ...
FOXBusiness - 23 Jul 2008
ARIUS is the developer of a proprietary antibody platform called FunctionFIRST(TM), which rapidly identifies and selects antibodies based on their ...
Roche to acquire antibody expert Arius in C$191 million deal - Pharma Times (...
Roche to acquire antibody expert Arius in C$191 million deal
Pharma Times (subscription), UK - 23 Jul 2008
A new day dawns and Roche announces another acquisition ? the Swiss healthcare major is buying Canadian antibody specialist Arius Research in an all-cash ...
Nabi Reports Positive Interim Results From Phase II Study of ... - RedOrbit
Nabi Reports Positive Interim Results From Phase II Study of ...
RedOrbit, TX - 8 hours ago
Nabi Biopharmaceuticals has announced positive interim results from its Phase II NicVAX schedule optimization immunogenicity study to assess the antibody ...
Roche to buy Canada's Arius Research for C$191 million - Reuters
Roche to buy Canada's Arius Research for C$191 million
Reuters - 23 Jul 2008
"Companies developing anti-cancer antibody-based drugs have seen considerable attention from large pharma companies seeking to augment their pipeline of ...
Roche Continues on a Roll; Getting Arius for $190M - BioWorld Online
Roche Continues on a Roll; Getting Arius for $190M
BioWorld Online, GA - 23 Jul 2008
By Catherine Hollingsworth Roche Holding AG continued its streak of biotech buyouts this week, moving to acquire antibody screening company Arius Research ...